Skip to main content
SpringerLink
Log in
Book cover

Stimulants pp 389–424Cite as

Psychotomimetic Drugs in Man

  • Chapter

Part of the book series: Handbook of Psychopharmacology ((SIBN,volume 11))

Abstract

Few drugs have had more scientific or social impact than the psychotomimetics. Few have been so peculiarly potent in their actions and so uniquely active in humans. While we may surmise that animals may be thinking strangely or perceiving erroneously or having marked alterations in mood, only man’s symbolizing ability lets us know for certain the degree to which relatively small amounts of psychotomimetics may profoundly alter mental functions. Therefore it would appear to be worth considering the pharmacology of these drugs in humans to see if we can grasp a few elusive clues concerning its mode of action.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aghajanina, G. K., and Bing, O. H., 1964, Persistence of lysergic acid diethylamide in the plasma of human subjects, Clin. Pharmacol. Ther. 5:611–614.

    Google Scholar 

  • Anderson, W. H., and O’Malley, J. E., 1972, Trifluoperazine for the “trailing” phenomenon, J.A.M.A. 220:1244.

    PubMed  Google Scholar 

  • Angrist, B., Rotrosen, J., and Gershon, S., 1974, Assessment of tolerance to the hallucinogenic effects of DOM, Psychopharmacologia 36:203–207.

    PubMed  Google Scholar 

  • Aptekar, R. G., and Mitchinson, M. J., 1970, Retroperitoneal fibrosis in two patients previously exposed to LSD. California Med. 113:77.

    PubMed  Google Scholar 

  • Aronson, H., Silverstein, A. B., and Klee, G. D., 1959, Influence of lysergic acid diethylamide (LSD-25) on subjective time. Arch. Gen. Psychiat. 1:469.

    Google Scholar 

  • Asher, H., 1971, “Trailing” phenomenon—A long-lasting LSD side effect, Am. J. Psychiat. 127:1233.

    PubMed  Google Scholar 

  • Axelrod, J., 1961, Enzymatic formation of psychotomimetic metabolites from normally occurring compounds, Science 134:343.

    PubMed  Google Scholar 

  • Ban, T. A., Lohrenz, J. J., and Lehman, H. E., 1961, Observations on the action of Sernyl— A new psychotropic drug, Canad. Psychiat. Assoc. J. 6:150–156.

    Google Scholar 

  • Barnett, B. E. W., 1971, Diazepam treatment for LSD intoxication, Lancet 2:270.

    PubMed  Google Scholar 

  • Benda, P., and Orsini, F., 1959, Experimental study of time estimation under LSD, Presse Med. 67:1000.

    Google Scholar 

  • Bente, D., Itil, T., and Schmid, E. E., 1963, Electroencephalographic studies concerning the action of LSD-25, Electroenceph. Clin. Neurophysiol. 9:359.

    Google Scholar 

  • Bercel, N. A., 1961, Clinical experience with a new type of anti-depressant drug: Ditran, J. Neuropsychiat. 2:271–278.

    Google Scholar 

  • Berlin, C. M., and Jacobson, C. B., 1972, Psychedelic drugs—A threat to reproduction?, Fed. Proc. 31:1326.

    PubMed  Google Scholar 

  • Berlin, L., Guthrie, T., Weider, A., Goodell, H., and Wolff, H. G., 1955, Studies in human cerebral function; the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity, J. Nerv. Ment. Dis. 122:487.

    PubMed  Google Scholar 

  • Bidder, T. G., Mandel, L. R., Ahn, H. S., Vanden Heuvel, W. J. A., and Walker, R. W., 1974, Blood and urinary dimethyltryptamine in acute psychotic disorders, Lancet 1:165.

    PubMed  Google Scholar 

  • Boardman, W. K., Goldstone, S., and Lhamon, W. T., 1957, Effects of lysergic acid diethylamide (LSD) on the time sense of normals. A preliminary report, Arch. Neurol. Psychiat. 78:321.

    Google Scholar 

  • Bowen, W. T., Soskin, R. A., and Chotlos, J. W., 1970, Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism, J. Nerv. Ment. Dis. 150:111–118.

    PubMed  Google Scholar 

  • Bowers, M. B., Jr., 1972a, Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings. Arch. Gen. Psychiat. 27:437.

    PubMed  Google Scholar 

  • Bowers, M. B., Jr., 1972b, Acute psychosis induced by psychotomimetic drug abuse. II. Neurochemical findings. Arch. Gen. Psychiat. 27:440.

    PubMed  Google Scholar 

  • Brawley, P., and Duffield, J. C., 1972, The pharmacology of hallucinogens, Pharmacol. Rev. 24:31–66.

    PubMed  Google Scholar 

  • Brune, G. G., and Himwich, H. E., Effects of methionine loading on the behavior of schizophrenic patients, J. Nerv. Ment. Dis. 134:447–450.

    Google Scholar 

  • Brune, G. G., Hohl, H. H., and Himwich, H. E., 1963, Urinary excretion of bufotenin-like substance in psychotic patients, J. Neuropsychiat. 5:14–17.

    Google Scholar 

  • Bryce, J. C., 1970, An evaluation of LSD in the treatment of chronic alcoholism, Canad. Psychiat. Assoc. J. 15:77–78.

    Google Scholar 

  • Carlson, V. R., 1958, Effect of lysergic acid diethylamide (LSD-25) on the absolute visual threshold, J. Comp. Physiol. Psychol. 51:528–531.

    PubMed  Google Scholar 

  • Chwelos, N., Blewett, D. B., Smith, C. M., and Hoffer, A., 1959, Use of lysergic acid diethylamide in the treatment of alcoholism, Quart, J. Stud. Alcohol 20:577–590.

    Google Scholar 

  • Cohen, S., 1971, The psychotomimetic agents, Prog. Drug Res. 15:68–102.

    Google Scholar 

  • David, J. M., 1960, Action of d-lysergic acid diethylamide (LSD-25) in compulsive neuroses, Sem. Med. (B. Air.) 117:1373–1399.

    Google Scholar 

  • Davies, B. M., 1961, Oral sernyl in obsessive states, J. Mental Sci. 107:109–114.

    Google Scholar 

  • Davis, H. K., Fork, H. F., Tupin, J. P., and Colvin, A., 1964, Clinical evaluation of JB-329 (Ditran), Dis. Nerv. Syst. 25:179–183.

    PubMed  Google Scholar 

  • Delay, J., Pichot, P., Laine, B., and Perse, J., 1954, Changes in personality produced by LSD. A study using the Rorschach test, Ann. Medicopsychol. (Paris) 112:1.

    Google Scholar 

  • Denson, R., and Sydiaha, D., 1970, A controlled study of LSD treatment in alcoholism and neurosis, Br. J. Psychiat. 116:443–445.

    Google Scholar 

  • Dewhurst, K., and Hatrick, J. A., 1972, Differential diagnosis and treatment of lysergic acid diethylamide induced psychosis, Practitioner 209:327.

    PubMed  Google Scholar 

  • Dishotsky, N. I., Loughman, W. D., Mogar, R. E., and Lipscomb, W. R., 1971, LSD and genetic damage: Is LSD chromosome damaging, carcinogenic, mutagenic, or teratogenic?, Science 172:431.

    PubMed  Google Scholar 

  • Duvoisin, R. C., and Katz, R., 1968, Reversal of central anticholinergic syndrome in man by physostigmine, J.AM.A. 206:1963–1964.

    Google Scholar 

  • Eastman, J. W., and Cohen, S. N., 1975, Hypertensive crisis and death associated with phencyclidine poisoning, J.A.M.A. 231:1270–1271.

    PubMed  Google Scholar 

  • Elmadjian, F., Hope, J. M., and Lamson, E. T., 1958, Excretion of epinephrine and norepinephrine under stress, Recent Progr. Hormone Res. 14:513–553.

    PubMed  Google Scholar 

  • Faillace, L. A., Vourlekis, A., and Szara, S., 1970, Hallucinogenic drugs in the treatment of alcoholism: A two-year follow-up, Comp. Psychiat. 11:51–56.

    Google Scholar 

  • Feigen, G. A., and Alles, G. A., 1955, Physiological concomitants of mescaline intoxication: A study of the effects upon normal subjects tested with submaximal doses, J. Clin. Exp. Psychopath. 7:167–178.

    Google Scholar 

  • Fink, M., 1959, EEG and behavioral effects of psychopharmacological agents, in Neuro-Psychopharmacology (Bradley, P. B., Deniker, P., and Radouco-Thomas, C., eds.), p. 441, Elsevier, Amsterdam.

    Google Scholar 

  • Finkelstein, B. A., 1961, Ditran, a psychotherapeutic advance: A review of one hundred and three cases, J. Neuropsychiat. 2:144–148.

    PubMed  Google Scholar 

  • Fischer, E., Vasguez, F. A., Fernandez, T. A., and Liskowske, I., 1961, Bufotenin in urine, Lancet 1:890–891.

    Google Scholar 

  • Flugel, F., and Bente, D., 1957, The akinetic-avolitional syndrome. Its significance of psychopharmacological research, Germ. Med. Monthly 2:51.

    Google Scholar 

  • Fookes, B. H., 1972, Psychosis after LSD, Lancet 1:1074.

    PubMed  Google Scholar 

  • Forrer, G. R., and Goldner, R. D., 1951, Experimental physiological studies with lysergic acid diethylamide (LSD-25), Arch. Neurol. Psychiat. 65:581–588.

    Google Scholar 

  • Forrest, J. A. H., and Tarala, R. A., 1973, 60 hospital admissions due to reactions to lysergide (LSD), Lancet 2:1310.

    PubMed  Google Scholar 

  • Fras, I., and Friedman, J. J., 1969, Hallucinogenic effects of nutmeg in adolescents, New York J. Med. 69:463–465.

    PubMed  Google Scholar 

  • Freedman, D. X., 1969, The psychopharmacology of hallucinogenic agents, Annu. Rev. Med. 20:409–418.

    PubMed  Google Scholar 

  • Friedhoff, A., and Van Winkle, E., 1962, The characteristics of an amine found in the urine of schizophrenic patients, J. Nerv. Ment. Dis. 135:550–555.

    PubMed  Google Scholar 

  • Friedman, S. A., and Hirsch, S. E., 1971, Extreme hyperthermia after LSD ingestion, J.A.M.A. 217:1549.

    PubMed  Google Scholar 

  • Gastaut, H., Ferrer, S., Castelis, C., Leserve, N., and Lushnat, K., 1953, Action of LSD on mental function and the EEG, Confin. Neurol. 13:102.

    PubMed  Google Scholar 

  • Giberti, F., and Gregoretti, L., 1955, Observations on the possible pharmacopsychiatric uses of LSD, Acad. Med. Torino 70(II):204.

    Google Scholar 

  • Gillin, J. C., Cannon, E., Magyar, R., Schwartz, M., and Wyatt, R. J., 1973, Failure of N,N-dimethyltryptamine to evoke tolerance in cats, Biol. Psychiat. 7:213–220.

    PubMed  Google Scholar 

  • Gogerty, J. H., and Dille, J. M., 1957, Pharmacology of d-lysergic acid morpholide, J. Pharmacol. Exp. Ther. 120:340–348.

    PubMed  Google Scholar 

  • Gorodetzky, C. W., and Isbell, H., 1964, A comparison of 2,3-dihydrolysergic acid diethylamide with LSD-25, Psychopharmacologia 6:229–233.

    PubMed  Google Scholar 

  • Grof, S., Soskin, R. A., Richards, W. A., and Kurland, A. A., 1973, DPT as an adjunct in psychotherapy of alcoholics, Int. Pharmacopsychiat. 8:104–115.

    Google Scholar 

  • Hoffer, A., and Osmund, H., 1959, The adrenochrome model and schizophrenia, J. Nerv. Ment. Dis. 128:18–35.

    PubMed  Google Scholar 

  • Hofmann, A., 1961, Chemical, pharmacological and medical aspects of psychotomimetics, J. Exp. Med. Sci. 5:31–51.

    PubMed  Google Scholar 

  • Hollister, L. E., 1962, Drug-induced psychoses and schizophrenic reactions: A critical comparison, Ann. N. Y. Acad. Sci. 96:80–88.

    PubMed  Google Scholar 

  • Hollister, L. E., and Friedhoff, A. J., 1966, Effects of 3,4-dimethoxyphenylethylamine in man, Nature 210:1377–1378.

    PubMed  Google Scholar 

  • Hollister, L. E., and Hartman, A. M., 1962, Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures, Compr. Psychiat. 3:235–241.

    PubMed  Google Scholar 

  • Hollister, L. E., Macnicol, M. F., and Gillespie, H. K., 1969a, An hallucinogenic amphetamine analog (DOM) in man, Psychopharmacologia 14:62–73.

    PubMed  Google Scholar 

  • Hollister, L. E., Shelton, J., and Krieger, G., 1969b, A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetamine in alcoholics, Am. J. Psychiat. 125:58–63.

    Google Scholar 

  • Hollister, L. E., Kanter, S. L., and Dronkert, A., 1970, Antidiuresis in man following lysergic acid diethylamide and mescaline, Behav. Neuropsychiat. 2:50–54.

    Google Scholar 

  • Hussain, M. Z., 1971, Toxic psychosis induced by asthma-dor, Canad. Med. Assoc. J. 104:326.

    PubMed  Google Scholar 

  • Itil, T. M., Keskiner, A., and Holden, J. M. C., 1969, The use of LSD and Ditran in the treatment of therapy resistant schizophrenics, Dis. Nerv. Syst. 30:93–103.

    PubMed  Google Scholar 

  • Jackson, B., and Reed, A., 1969, Catnip and the alteration of consciousness, J.A.M.A. 207:1349–1350.

    PubMed  Google Scholar 

  • Jacobson, C. B., and Berlin, C. M., 1972, Possible reproductive detriment in LSD users, J.A.M.A. 222:1367.

    PubMed  Google Scholar 

  • Johnson, F. G., 1969, LSD in the treatment of alcoholism, Am. J. Psychiat. 126:481–487.

    PubMed  Google Scholar 

  • Johnstone, R. E., 1973, A ketamine trip, Anesthesiology 39:460–461.

    PubMed  Google Scholar 

  • Jost, F., 1957, The therapeutic use of LSD in clinical psychiatry. Preliminary communication, Wien. Klin. Wochenschr. 69:647.

    Google Scholar 

  • Jovanovic, D., Kandic, B., and Kronja, T., 1960, Some experiences on the treatment of psychiatric patients with lysergic acid diethylamide (LSD-25): Preliminary report, Vojnosanit. Pregl. 17:251.

    Google Scholar 

  • Karn, W. N., Jr., Mead, B. T., and Fishman, J. J., 1961, Effect of Ditran on chronic, regressed mental patients, Dis. Nerv. Syst. 22:1–5.

    Google Scholar 

  • Kies, M. W., Horst, D., Evarts, E. V., and Goldstein, N. P., 1957, Antidiuretic effect of lysergic acid diethylamide in humans, Arch. Neurol. Psychiat. 77:267–269.

    Google Scholar 

  • Klee, G. D., Bertino, J., Weintraub, W., and Callaway, E., 1961, The influence of varying dosage on the effects of lysergic acid diethylamide (LSD-25) in humans, J. Nerv. Ment. Dis. 132:404–409.

    PubMed  Google Scholar 

  • Kleptisz, A., and Racy, J., 1973, Homicide and LSD, J.A.M.A. 223:429.

    Google Scholar 

  • Klock, J. C., Boerner, U., and Becker, C. E., 1974, Coma, hyperthermia and bleeding associated with massive LSD overdose, Western J. Med. 120:183.

    Google Scholar 

  • Krill, A. E., Wieland, A. M., and Ostfeld, A. M., 1960, The effect of two hallucinogenic agents on human retinal function, Arch. Opthal. 64:724–733.

    Google Scholar 

  • Krus, D. M., Wapner, S., Freeman, H., and Casey, T. M., 1963, Differential behavioral responsivity to LSD-25, Arch. Gen. Psychiat. 8:557–563.

    PubMed  Google Scholar 

  • Kurland, A., Savage, C., Pahnke, W. N., Grof, S., and Olsson, J. E., 1971, LSD in the treatment of alcoholics, Pharmackopsychiatrie Neuro-Psychopharmakologie 4:83–94.

    Google Scholar 

  • Lefkowitz, S. S., Hung, C. Y., and Geber, W. F., 1973, The effect of psychotomimetic drugs on interferon production, Res. Comm. Chem. Path. Pharmacol. 5:885.

    Google Scholar 

  • Levick, L. J., and Levick, S. N., 1971, Testicular choriocarcinoma in LSD users: Coincidence or cause?, J.A.M.A. 217:475.

    PubMed  Google Scholar 

  • Lewis, D. J., and Sloane, R. B., 1958, Therapy with lysergic acid diethylamide, J. Clin. Exp. Psychopath. 19:19–31.

    PubMed  Google Scholar 

  • Liden, C. B., Lovejoy, F. H., Jr., and Costello, C. E., 1975, Phencyclidine: Nine cases of poisoning, J.A.M.A. 234:513–516.

    PubMed  Google Scholar 

  • Lieberman, A. N., Bloom, W., Kishore, P. S., and Lin, J. P., 1974, Carotid artery occlusion following ingestion of LSD, Stroke 5:213.

    PubMed  Google Scholar 

  • Ling, T. M., and Buckman, J., 1960, The use of lysergic acid in individual psychotherapy, Proc. Roy. Soc. Med. 53:927.

    PubMed  Google Scholar 

  • Linton, H. B., and Langs, R. J., 1962, Subjective reactions to lysergic acid diethylamide (LSD-25), Arch. Gen. Psychiat. 6:352–368.

    Google Scholar 

  • Long, S. Y., 1972, Does LSD induce chromosomal damage and malformations? A review of the literature, Teratology 6:75.

    PubMed  Google Scholar 

  • Luby, E. D., Cohen, B. D., Roxenbaum, G., and Gottlieb, J. S., 1959, Study of a new schizophrenomimetic drug: Sernyl, Arch. Neuro. Psychiat. 81:363–368.

    Google Scholar 

  • Ludwig, A., Levine, J., Stark, L., and Lazar, R., 1969, A clinical study of LSD treatment in alcoholism, Am. J. Psychiat. 126:59–69.

    PubMed  Google Scholar 

  • MacLean, J. R., MacDonald, D. C., Byrne, U. P., and Hubbard, A. M., 1961, The use of LSD-25 in the treatment of alcoholism and other psychiatric problems, Quart. J. Stud. Alcohol 22:34–45.

    PubMed  Google Scholar 

  • Malcolm, R., and Miller, W. C., 1972, Dimenhydrinate (Dramamine) abuse: Hallucinogenic experiences with a proprietary antihistamine, Am. J. Psychiat. 128:1012–1013.

    PubMed  Google Scholar 

  • Malitz, S., Wilkens, B., Rochrigo, W. C., and Hoch, P. H., 1960, A clinical comparison of three related hallucinogens, Psychiat. Quart. 34:333–345.

    PubMed  Google Scholar 

  • Martin, J., 1957, LSD (lysergic acid diethylamide) treatment of chronic psychoneurotic patients under day-hospital conditions, Int. J. Soc. Psychiat. 3:188.

    Google Scholar 

  • Maugh, T. H., 1973, LSD and the drug culture: New evidence of hazard, Science 179:1221.

    PubMed  Google Scholar 

  • McCabe, O. L., Savage, C., Kurland, A., and Unger, S., 1972, Psychedelic (LSD) therapy of neurotic disorders: Short term effects, J. Psychedelic Drugs 5:18–28.

    Google Scholar 

  • McGlothlin, W. H., and Arnold, D. O., 1971, LSD revisited. A ten-year follow-up of medical LSD use, Arch. Gen. Psychiat. 24:35–49.

    PubMed  Google Scholar 

  • McIsaac, W., 1961, A biochemical concept of mental disease, Postgrad. Med. 30:111–118.

    PubMed  Google Scholar 

  • McWilliams, S. A., and Tuttle, R. J., 1973, Long-term psychological effects of LSD, Psych. Bull. 79:341.

    Google Scholar 

  • Meltzer, H., Pahnke, W., Kurland, A., and Henkin, R., 1970, Serum CPK and aldolase activity in man following controlled administration of psychotomimetic drugs, Psychopharmacologia 16:419–425.

    PubMed  Google Scholar 

  • Merlis, S., 1957, The effects of mescaline sulfate in chronic schizophrenia, J. Nerv. Ment. Dis. 125:432–434.

    PubMed  Google Scholar 

  • Messiha, F. S., and Grof, S., 1973, d-Lysergic acid diethylamide (LSD)—Effect on biogenic amines excretion in man, Biochem. Pharmacol. 22:2352–2354.

    PubMed  Google Scholar 

  • Monroe, R. R., Heath, R. G., Mickle, W. A., and Llewellyn, R. C., 1957, Correlation of rhinencephalic electrograms with behavior. A study on humans under the influence of LSD and mescaline, Electroenceph. Clin. Neurophysiol. 9:623.

    PubMed  Google Scholar 

  • Moskowitz, D., 1971, Use of haloperidol to reduce LSD flashbacks, Milit. Med. 136:754.

    Google Scholar 

  • Muller, D. J., 1967, Unpublicized hallucinogens, J.A.M.A. 202:650–651.

    PubMed  Google Scholar 

  • Muller, D. J., 1971, ECT in LSD psychosis: A report of three cases, Am. J. Psychiat. 128:131.

    Google Scholar 

  • Murphree, H. V., Jenney, E. H., and Pfeiffer, C. C., 1962, Quantitative electroencephalographic analysis of the effects of lysergic acid diethylamide (LSD-25) and d-amphetamine in man, Fed. Proc. 21:337.

    Google Scholar 

  • Narasimhachari, N., Heller, B., Spaide, J., Haskovec, L., Fujimori, M., Tabushi, K., and Himwich, H. E., 1971, Urinary studies of schizophrenics and controls, Biol. Psychiat. 3:9–20.

    PubMed  Google Scholar 

  • Nava, C., 1972, Descrizione di un caso di allergia a lisergidi (derivati dell’amide dell’acido lisergico), Med. Lavoro (Milano) 63:57.

    Google Scholar 

  • O’Reilly, P. O., and Funk, A., 1964, LSD in chronic alcoholism, Canad. Psychiat. Assoc. J. 9:258–260.

    Google Scholar 

  • Orsini, F., and Bend a, P., 1959, Experimental study of slowing of performance by LSD, Ann. Med. Psychol. 117:519.

    Google Scholar 

  • Orsini, F., and Benda, P., 1960, The mirror-image draw test under LSD-25, Ann. Medicopsychol. 118:809.

    PubMed  Google Scholar 

  • Osmond, H., and Smythies, J., 1952, Schizophrenia: A new approach, J. Mental Sci. 98:309–315.

    Google Scholar 

  • Ostfeld, A. M., Visotsky, H., Abood, L., and Lebovitz, B. Z., 1959, Studies with a new hallucinogen. Some dosage-response data for JB-318, Arch. Neurol. Psychiat. 81:256–263.

    Google Scholar 

  • Painter, J. C., Shanor, S. P., and Winek, C. L., 1971, Nutmeg poisoning—A case report, Clin. Toxicol. 4:1–4.

    PubMed  Google Scholar 

  • Panayotopoulos, D. J., and Chisholm, D. D., 1970, Hallucinogenic effect of nutmeg, Br. Med. J. 1:754.

    PubMed  Google Scholar 

  • Pennes, H. H., and Hoch, P. H., 1957, Psychotomimetics, clinical and theoretical considerations. Harmine, Win-2299, and Nalline, Am. J. Psychiat. 113:887–892.

    PubMed  Google Scholar 

  • Peretz, E.i., Smythies, J. R., and Gibson, W. C., 1955, A new hallucinogen: 3,4,5-Trimethoxyphenyl-b-aminopropane with notes on the stroboscopic phenomenon, J. Ment. Sci. 101:317–329.

    PubMed  Google Scholar 

  • Pollin, W., Cardon, P. V., and Kety, S. S., 1961, Effects of amino acid feedings in schizophrenic patients treated with iproniazid, Science 133:104–105.

    PubMed  Google Scholar 

  • Radouco-Thomas, S., Schwarz, T. H., and Michaud, R., 1974, Psychotomimetics and cerebral cations, in Pharmacology, Toxicology and Abuse of Psychotomimetics (Hallucinogens) (S. Radouco-Thomas, A. Villeneuve, and C. Radouco-Thomas, eds.), pp. 239–248, Les Presses de l’Université Laval, Quebec.

    Google Scholar 

  • Raine, A. C., 1972, Chronic ocular symptoms following the use of hallucinogenic agents, J. Psychedelic Drugs 5:81.

    Google Scholar 

  • Reich, P., and Hepps, R. B., 1972, Homicide during a psychosis induced by LSD, J.A.M.A. 219:869.

    PubMed  Google Scholar 

  • Robinson, J. T., Davies, L. D., Sack, E. L. N. S., and Morrissey, J. P., 1963, A controlled trial of abreaction with lysergic acid diethylamide (LSD-25), Br. J. Psychiat. 109:46–55.

    Google Scholar 

  • Rosenbaum, G., Cohen, B. D., Luby, E. D., Gottlieb, J. S., and Yelen, D., 1959, Comparison of Sernyl with other drugs. Simulation of schizophrenic performance with Sernyl, LSD-25, and amobarbital (Amytal) sodium; I. Attention, motor function, and proprioception, Arch. Gen. Psychiat. 1:651.

    Google Scholar 

  • Rosenberg, D. E., Isbell, H., and Miner, E. J., 1963, Comparison of a placebo, N-dimethyltryptamine, and 6-hydroxy-N-dimethyl-tryptamine in man, Psychopharmacologia 4:39–42.

    PubMed  Google Scholar 

  • Rosenberg, D. E., Isbell, H., Miner, E. J., and Logan, C. R., 1964, The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide, Psychopharmacologia 5:217–227.

    PubMed  Google Scholar 

  • Ruiz, O. C., 1958, Experimental Psychoses. Comparative Studies of Those Produced by LSD-25, Mescaline and cannabis indica with Particular Regard to Psychiatric Problems, Thesis, Univ. of Barcelona 1957, Frontis, Barcelona.

    Google Scholar 

  • Saavedra, J. M., and Axelrod, J., 1972, Psychotomimetic N-methylated tryptamines: Formation in brain in vivo and in vitro, Science 172:1365–1366.

    Google Scholar 

  • Sandison, R. A., and Whitelaw, J. D. A., 1957, Further studies in the therapeutic value of lysergic acid diethylamide in mental illness, J. Ment. Sci. 103:332.

    PubMed  Google Scholar 

  • Sandison, R. A., Spencer, A. M., and Whitelaw, J. D. A., 1954, The therapeutic value of lysergic acid diethylamide in mental illness, J. Ment. Sci. 100:491.

    PubMed  Google Scholar 

  • Sankar, D. V. Siva, 1975, LSD—A Total Study, PJD Publ. Ltd., Westbury, New York.

    Google Scholar 

  • Sarwer-Foner, G. J., 1972, Some clinical and social aspects of lysergic acid diethylamide. II. Psychosomatics 13:309.

    PubMed  Google Scholar 

  • Savage, C., 1952, Lysergic acid diethylamide (LSD-25). A clinical-psychological study, Am. J. Psychiat. 108:896.

    PubMed  Google Scholar 

  • Savage, C., and McCabe, O. L., 1973, Residential psychedelic (LSD) therapy for the narcotic addict, Arch. Gen. Psychiat. 28:808–814.

    PubMed  Google Scholar 

  • Savage, C., McCabe, O. L., Kurland, A. A., and Hanlon, T., 1973, LSD—assisted psychotherapy in the treatment of severe chronic neurosis, J. Altered States of Consciousness 1:31–47.

    Google Scholar 

  • Schatz, H., and Mendelblatt, F., 1973, Solar retinopathy from sun-gazing under the influence of LSD, Br. J. Ophthal. 57:270.

    Google Scholar 

  • Schwarz, B. E., Sem-Jacobsen, C. W., and Petersen, M. C., 1956, Effects of mescaline, LSD-25 and adrenochrome on depth electrograms in man, Arch. Neurol. Psychiat. 75:579.

    Google Scholar 

  • Sedman, G., and Kenna, J. C., 1965, The use of LSD-25 as a diagnostic aid in doubtful cases of schizophrenia, Br. J. Psychiat. 111:96–100.

    Google Scholar 

  • Shirahashi, K., 1960, Electroencephalographic study of mental disturbances experimentally induced by LSD-25, Folia Psychiat. Neurol. 14:140.

    Google Scholar 

  • Shulgin, A. T., 1964, 3-Methoxy-4,5-methylenedixoy amphetamine, a new psychotomimetic agent, Nature 201:1120–1121.

    PubMed  Google Scholar 

  • Shulgin, A. T., Sargent, T., and Naranjo, C., 1973, Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA), Pharmacology 10:12–18.

    PubMed  Google Scholar 

  • Siegel, M., 1965, A sensitive method for the detection of N,N-dimethylserotonin (Bufotenin) in urine: Failure to demonstrate its presence in the urine of schizophrenic and normal subjects, J. Psychiat. Res. 3:205–211.

    PubMed  Google Scholar 

  • Silverstein, A. B., and Klee, G. D., 1960, The effect of lysergic acid diethylamide on dual pursuit performance, J. Clin. Exp. Psychopath. 21:300–302.

    Google Scholar 

  • Sjoberg, B. M., Jr., and Hollister, L. E., 1965, The effects of psychotomimetic drugs on primary suggestibility, Psychopharmacologia 8:251–262.

    PubMed  Google Scholar 

  • Smith, C. M., 1958, A new adjunct to the treatment of alcoholism: The hallucinogenic drugs, Quart, J. Stud. Alcohol 19:406.

    Google Scholar 

  • Snyder, S. H., 1973, Amphetamine psychosis: A “model” schizophrenia mediated by catecholamines, Am. J. Psychiat. 130:61–67.

    PubMed  Google Scholar 

  • Solyom, L., and Kingstone, E., 1973, An obsessive neurosis following morning glory seed ingestion treated by aversion relief, J. Behav. Ther. Exp. Psychiat. 4:293.

    Google Scholar 

  • Soskin, R. A., 1973, The use of LSD in time-limited psychotherapy, J. Nerv. Ment. Dis. 157:410–419.

    PubMed  Google Scholar 

  • Stroo, H. H., 1967, A case of transient schizophrenia due to scopolamine poisoning, Virginia Med. Monthly 94:107–109.

    PubMed  Google Scholar 

  • Takashina, K., 1960, Physiological studies of visual symptoms due to the effects of hallucinogenic agent LSD-25 on the critical fusion frequency of flicker, the electric flicker threshold, and the intensity threshold for light, Psychiat. Neurol. 62:1745.

    Google Scholar 

  • Tec, L., 1971, Phenothiazine and biperiden in LSD reactions, J.A.M.A. 215:980.

    PubMed  Google Scholar 

  • Teitelbaum, D. T., 1968, Stramonium poisoning in “teeny-boppers,” Ann. Intern. Med. 68:174–175.

    PubMed  Google Scholar 

  • Thiessen, P. N., and Cook, D. A., 1973, The properties of 3,4-methylenedioxy-amphetamine (MDA). I. A reveiw of the literature, Clin. Toxicol. 6:45–52.

    PubMed  Google Scholar 

  • Thurlow, H. J., and Girvin, J. P., 1971, Use of anti-epileptic medication in treating “flashbacks” from hallucinogenic drugs. Canad. Med. Assoc. J. 105:947.

    PubMed  Google Scholar 

  • Van Dusen, W., Wilson, W., Miners, W., and Hook, H., 1964, Lysergic Acid Treatment of Alcoholism, Prepubl. Rep. #325, California State Department of Mental Hygiene, Sacramento, California.

    Google Scholar 

  • Wagner, J. G., Aghajanian, G. K., and Bing, O. H. L., 1968, Correlation of performance test scores with “tissue concentration” of lysergic acid diethylamide in human subjects, Clin. Pharmacol. Ther. 9:635–638.

    PubMed  Google Scholar 

  • Weintraub, W., Silverstein, A. B., and Klee, G. D., 1959, The effect of LSD on the associative processes, J. Nerv. Ment. Dis. 128:409–414.

    PubMed  Google Scholar 

  • Wyatt, R. J., Saavedra, J. M., and Axelrod, J., 1973a, A dimethyltryptamine-forming enzyme in human blood, Am. J. Psychiat. 130:754–760.

    PubMed  Google Scholar 

  • Wyatt, R. J., Mandel, L. R., Ahn, H. S., Walker, R. W., and Vanden Heuvel, W. J. A., 1973b, Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients, Psychopharmacologia 31:265–270.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Veterans Administration Hospital, and Stanford University School of Medicine, Palo Alto, California, USA

    Leo E. Hollister

Authors
  1. Leo E. Hollister
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology, University of Cambridge, UK

    Leslie L. Iversen

  2. Department of Psychology, University of Cambridge, UK

    Susan D. Iversen

  3. Departments of Pharmacology and Psychiatry, School of Medicine, The Johns Hopkins University, USA

    Solomon H. Snyder

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Plenum Press, New York

About this chapter

Cite this chapter

Hollister, L.E. (1978). Psychotomimetic Drugs in Man. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Stimulants. Handbook of Psychopharmacology, vol 11. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0510-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0510-2_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0512-6

  • Online ISBN: 978-1-4757-0510-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation